Enorama Pharma AB (publ) (STO:ERMA)
Sweden
· Delayed Price · Currency is SEK 0.770
+0.096 (14.24%)
Mar 9, 2026, 5:11 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 57.43 million as of March 9, 2026. Its market cap has decreased by -57.03% in one year.
Market Cap
57.43M
Enterprise Value
50.87M
Revenue
3.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
Market Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 57.43M, an increase of 60.31%. That is a compound annual growth rate of 4.96%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Newbury Pharmaceuticals AB | 32.83M |
| Vivesto AB | 91.67M |
| Gabather AB | 21.83M |
| Klaria Pharma Holding AB (publ.) | 196.78M |
| Moberg Pharma AB | 487.40M |
| Enzymatica AB | 495.18M |
| Dicot Pharma AB | 608.83M |
| Nanexa AB | 649.29M |